Fasenra is a medication that has been developed to treat severe eosinophilic asthma in adults and adolescents aged 12 years and older. This drug is a monoclonal antibody that works by targeting and blocking a specific protein in the body that is responsible for causing inflammation in the airways.

For patients who have been struggling with severe asthma symptoms despite using other medications, Fasenra can be a game-changer. By reducing the number of eosinophils in the blood, this medication can help to decrease airway inflammation and improve lung function. This can lead to a reduction in asthma attacks, as well as a decrease in the need for oral corticosteroids.

It is important to note that Fasenra is not a rescue medication and should not be used to treat sudden asthma attacks. Instead, it is meant to be used as a maintenance therapy to help control symptoms and reduce the frequency of exacerbations.

As with any medication, Fasenra does come with potential side effects. These can include injection site reactions, headache, and sore throat. In rare cases, more serious side effects such as allergic reactions or anaphylaxis may occur. It is important to discuss the risks and benefits of Fasenra with your healthcare provider before starting treatment.

Overall, Fasenra has shown promising results in clinical trials and has provided relief for many patients with severe eosinophilic asthma. If you think you may benefit from this medication, be sure to talk to your doctor about whether Fasenra is right for you.